Morgan Stanley Maintains Overweight on Omada Health, Lowers Price Target to $30
Morgan Stanley analyst Craig Hettenbach maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $32 to $30.
Login to comment